Muraleva, N. A., Kolosova, N. G., & Stefanova, N. A. (2021). MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats. Antioxidants (Basel).
Citación estilo ChicagoMuraleva, Natalia A., Nataliya G. Kolosova, and Natalia A. Stefanova. "MEK1/2-ERK Pathway Alterations As a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats." Antioxidants (Basel) 2021.
Cita MLAMuraleva, Natalia A., Nataliya G. Kolosova, and Natalia A. Stefanova. "MEK1/2-ERK Pathway Alterations As a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats." Antioxidants (Basel) 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.